Inhaled drug formulation involves consideration of multiple factors, including the properties of the API, the needs of the target patient population, the delivery requirements, and the choice of ...
Deerfield, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- DEERFIELD, IL. February 27, 2025 – Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on ...
Understanding the impact of API solubility on the performance of a given drug product and determining ways to enhance dissolution rates is critical to ensuring your product makes it to market, into ...
(MENAFN- Market Press Release) August 20, 2023 9:42 pm - When designing pharmaceutical preparations, the choice of excipients should not only consider the dosage form factors and excipient functions ...
CD Formulation, a leading provider of analytical and formulation services, has recently announced the launch of its new Genotoxic Impurity (GI) Testing services. This innovative offering aims to ...
Pimavanserin is an atypical antipsychotic used to treat hallucinations and delusions associated with Parkinson’s disease psychosis. The medication is marketed globally as Nuplazid, and has become a ...
Pharmaceutical companies are increasingly focusing on acquisitions in the Active Pharmaceutical Ingredients (API) and formulation space to consolidate market share and diversify portfolios, global ...
In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
Biocon’s momentum in its formulations business balanced the challenges it faced in pricing pressures on its API (active pharmaceutical ingredient) business and could soon overtake the share of APIs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback